M33.29

Clinical Causes: Autoimmune response where the body's immune system mistakenly attacks its own muscle and organ tissues. Genetic predisposition that increases susceptibility to autoimmune diseases. Environmental factors such as infections or exposures to certain chemicals that may trigger immune responses. Infections caused by viruses or bacteria could potentially play a role in initiating autoimmune reactions.

Key Symptoms: Progressive muscle weakness, particularly in the muscles closest to the trunk such as shoulders and hips. Difficulty swallowing or speaking if the muscles involved in these functions are affected. Muscle pain, tenderness, or swelling in affected areas. Fatigue and general weakness that worsens with activity. Symptoms involving other organs might include: Lung problems, such as shortness of breath or cough due to inflammation of lung tissue. Heart issues like arrhythmias or myocarditis, leading to chest pain or irregular heartbeat. Skin changes, such as rashes or discoloration, especially if associated with cutaneous symptoms.

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests may reveal elevated muscle enzymes like creatine kinase (CK) indicating muscle breakdown. Electromyography (EMG) can assess electrical activity in muscles, while muscle biopsies help confirm inflammation and tissue damage. Additional tests, such as lung function tests or heart evaluations, may be performed to assess the involvement of other organs. Imaging techniques like MRI can visualize muscle inflammation and monitor disease progression.

Treatment Protocols: Corticosteroids, such as prednisone, to reduce muscle inflammation and immune activity. Immunosuppressive drugs like azathioprine or methotrexate to suppress abnormal immune responses. Physical therapy to improve muscle strength, flexibility, and function. Monitoring and managing organ-specific symptoms, such as respiratory or cardiac support if involved. In some cases, intravenous immunoglobulin (IVIG) therapy may be used to modulate immune function. Addressing complications early and providing supportive care to maintain quality of life.